Curecumin™ – a product of Bioponic Phytoceuticals, Inc. – is a Bioresonant Phytotherapeutic® form of curcumin in a liquid delivery system.

Now, a recent study has identified Curecumin™ as a possible important treatment against skin cancer.

“The diet-derived cancer preventive agent, curcumin, inhibits skin cancer cell proliferation and tumor formation.

We show that curcumin suppresses the differentiation agent-dependent activation of hINV gene expression and that an AP1 transcription factor DNA binding site in the hINV gene is required for this regulation.

These studies provide important insights regarding the mechanism whereby curcumin acts as a chemopreventive agent in normal human epidermis.”

The said study was conducted at the Departments of Physiology and Biophysics, Dermatology, Biochemistry, Reproductive Biology, and Oncology, at Case Western Reserve University School of Medicine in Cleveland, Ohio.

Results have been published in the Journal of Biological Chemistry.

Find more details from the full report.

Post from: Blisstree

Curecumin™ Could be an Effective Treatment for Skin Cancer

Now, Curecumin™ – a Bioresonant Phytotherapeutic® form of Turmeric containing curcumin and a product of Bioponic Phytoceuticals, Inc. (OTC: BPYT) – could be an important treatment for prostate cancer.

At least based on scientific articles posted at UroToday and published at Cancer Research.

According to Steven M. Schorr, Chairman & CEO of Bioponic Phytoceuticals, Inc.:

“We are particularly interested in the potential of our Curecumin™ product to provide a viable treatment strategy for those with prostate cancer. If proven effective, we may have an efficacious, cost effective, natural treatment for prostate cancer sufferers.”

Read the full report.

Post from: Blisstree

CureCumin™ against Prostate Cancer